The goal of this clinical trial is to study the differences in gastric microbiota (Diversity index) between patients who were infected with CagA-positive Helicobacter pylori and CagA-negative Helicobacter pylori. The main question it aims to answer are: The effect of Helicobacter pylori typing (CagA status) on gastric microbiota, what is the different? Patients indicated for EGD at Siriraj Endoscopic Center will undergo a Helicobacter pylori test (Rapid urease test) If the result is positive, a stomach biopsy for gastric microbiota testing and CagA antibody testing will be conducted. Then, the patients will be divided into two groups: CagA-positive Helicobacter pylori and CagA-negative Helicobacter pylori. To compare the differences in gastric microbiota in terms of species and biodiversity, as well as endoscopic results, etc.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
64
Stomach biopsy for gastric microbiota testing (16S RNA sequencing)
Faculty of internal medicine siriraj hospital, Mahidol university
Bangkok Noi, Bangkok, Thailand
The differences in gastric microbiota (Diversity index)
Diversity index: Shannon index, Simpson index
Time frame: On the 1 day of EGD
Microbiota composition
Prevalence of microbiota species
Time frame: On the 1 day of EGD
Endoscopic finding
Endoscopic finding was described by investigators
Time frame: During the EGD
Pathological finding
Pathological finding was described by pathologist
Time frame: Within 2 week after EGD
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.